Evaluation of Safety and Performance in Robots for Knee Replacement Surgery Based on Standards

2016 ◽  
pp. 117-126
Author(s):  
Youngjin Moon ◽  
Dukhee Lee ◽  
Seongjun Kim ◽  
Songe Choi ◽  
Jaesoon Choi
Keyword(s):  
Knee Replacement ◽  
Knee Replacement Surgery ◽  
Replacement Surgery ◽  
And Performance

Patient Blood Management in Elective Total Hip- and Knee-replacement Surgery (Part 2)

2014 ◽  
Vol 120 (4) ◽  
pp. 852-860 ◽  
Author(s):  
Cynthia So-Osman ◽  
Rob G. H. H. Nelissen ◽  
Ankie W. M. M. Koopman-van Gemert ◽  
Ewoud Kluyver ◽  
Ruud G. Pöll ◽  
...  
Keyword(s):  
Knee Replacement ◽  
Control Group ◽  
Transfusion Rate ◽  
Cell Saver ◽  
Patient Blood Management ◽  
Blood Management ◽  
Knee Replacement Surgery ◽  
Total Hip ◽  
Replacement Surgery ◽  
Preoperative Hemoglobin

Abstract Background: Patient blood management is introduced as a new concept that involves the combined use of transfusion alternatives. In elective adult total hip- or knee-replacement surgery patients, the authors conducted a large randomized study on the integrated use of erythropoietin, cell saver, and/or postoperative drain reinfusion devices (DRAIN) to evaluate allogeneic erythrocyte use, while applying a restrictive transfusion threshold. Patients with a preoperative hemoglobin level greater than 13 g/dl were ineligible for erythropoietin and evaluated for the effect of autologous blood reinfusion. Methods: Patients were randomized between autologous reinfusion by cell saver or DRAIN or no blood salvage device. Primary outcomes were mean intra- and postoperative erythrocyte use and proportion of transfused patients (transfusion rate). Secondary outcome was cost-effectiveness. Results: In 1,759 evaluated total hip- and knee-replacement surgery patients, the mean erythrocyte use was 0.19 (SD, 0.9) erythrocyte units/patient in the autologous group (n = 1,061) and 0.22 (0.9) erythrocyte units/patient in the control group (n = 698) (P = 0.64). The transfusion rate was 7.7% in the autologous group compared with 8.3% in the control group (P = 0.19). No difference in erythrocyte use was found between cell saver and DRAIN groups. Costs were increased by €298 per patient (95% CI, 76 to 520). Conclusion: In patients with preoperative hemoglobin levels greater than 13 g/dl, autologous intra- and postoperative blood salvage devices were not effective as transfusion alternatives: use of these devices did not reduce erythrocyte use and increased costs.

scholarly journals How safe is primary knee replacement surgery? Perioperative complication rates in Northern Illinois, 1993-1999

2004 ◽  
Vol 51 (1) ◽  
pp. 110-116 ◽  
Author(s):  
Joe Feinglass ◽  
Hagay Amir ◽  
Patricia Taylor ◽  
Ithai Lurie ◽  
Larry M. Manheim ◽  
...  
Keyword(s):  
Knee Replacement ◽  
Complication Rates ◽  
Knee Replacement Surgery ◽  
Replacement Surgery ◽  
Perioperative Complication

scholarly journals Serious games for knee replacement surgery procedure education and training

2010 ◽  
Vol 2 (2) ◽  
pp. 3483-3488 ◽  
Author(s):  
Hamed Sabri ◽  
Brent Cowan ◽  
Bill Kapralos ◽  
Mark Porte ◽  
David Backstein ◽  
...  
Keyword(s):  
Knee Replacement ◽  
Serious Games ◽  
Education And Training ◽  
Knee Replacement Surgery ◽  
Replacement Surgery ◽  
And Training

scholarly journals Self-Reported Knee Instability Before and After Total Knee Replacement Surgery

2016 ◽  
Vol 68 (4) ◽  
pp. 463-471 ◽  
Author(s):  
Genevieve Fleeton ◽  
Alison R. Harmer ◽  
Lillias Nairn ◽  
Jack Crosbie ◽  
Lyn March ◽  
...  
Keyword(s):  
Total Knee Replacement ◽  
Knee Replacement ◽  
Knee Instability ◽  
Knee Replacement Surgery ◽  
Replacement Surgery ◽  
Total Knee Replacement Surgery ◽  
Before And After ◽  
Total Knee
Sign in / Sign up

Export Citation Format

Share Document